References
- Writing Group for the Women's Health Initiative Investigators. Risks and benefits of estrogen plus progestin in healthy postmenopausal women. Principal results from the Women's Health Initiative randomized controlled trial. J Am Med Assoc 2002;288:321–33
- Brooker M. Canned HRT trial leaves un-answered questions. The Christchurch Press 2002;Friday October 25:A3
- Fontanarosa PB, DeAngelis CD. The importance of the journal embargo. J Am Med Assoc 2002;288:748–50
- Patel A, Norton R, MacMahon S. The HRT furore: getting the message right. Med J Aust 2002;177:345–6
- Zandi PB, Carlson MC, Plassman BL, et al. for the Cache County Memory Study Investigators. Hormone replacement therapy and incidence of Alzheimer disease in older women. The CacheCounty Study. J Am Med Assoc 2002;288: 2123–9
- Mikkola TS, Clarkson TB. Estrogen replacement therapy, atherosclerosis, and vascular function. Cardiovasc Res 2002;53:605–19
- NAMS. Amended Report from the NAMS Advisory Panel on Postmenopausal Hormone Therapy. Published October 3,2002, amended and revised, October 6,2002
- Stevenson JC, Whitehead MI. Hormone replace-ment therapy. Br Med J 2002;325:113–14
- Resnick SM, Henderson VW. Hormone therapy and risk of Alzheimer disease. J Am Med Assoc 2002;288:2170–2
- Rossouw JE. Cardiovascular diseases. Presented at the National Institutes of Health (NIH) Conference. Scientific Workshop — Menopausal Hormone Therapy, October 23–24,2002